1. Up Front

   Up Front 25 May 2022 Pages: 1067 - 1068

   

2. Unravelling innervation of pancreatic islets

   • Rollie F. Hampton
   • Maria Jimenez-Gonzalez
   • Sarah A. Stanley

   Review 29 March 2022 Pages: 1069 - 1084

   

3. Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

   • Simke W. Waijer
   • Priya Vart
   • Hiddo J. L. Heerspink

   Article Open access 21 April 2022 Pages: 1085 - 1097

   

4. Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway

   • Celien Tigchelaar
   • Mark L. van Zuylen
   • Anthony R. Absalom

   Article Open access 05 April 2022 Pages: 1098 - 1107

   

5. Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes

   • Clemens Kamrath
   • Sascha R. Tittel
   • Reinhard W. Holl

   Article Open access 30 April 2022 Pages: 1108 - 1118

   

6. Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes

   • Fenglei Wang
   • Megu Y. Baden
   • Frank B. Hu

   Article 08 April 2022 Pages: 1119 - 1132

   

7. Healthful eating patterns, serum metabolite profile and risk of diabetes in a population-based prospective study of US Hispanics/Latinos

   • Guo-Chong Chen
   • Jin Choul Chai
   • Qibin Qi

   Article 31 March 2022 Pages: 1133 - 1144

   

8. Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults

   • Huijun Wang
   • Wanglong Gou
   • Ju-Sheng Zheng

   Article Open access 31 March 2022 Pages: 1145 - 1156

   

9. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women’s Health Across the Nation (SWAN)

   • Sung Kyun Park
   • Xin Wang
   • Siobán D. Harlow

   Article 11 April 2022 Pages: 1157 - 1168

   

10. Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study

    • Soraya Soulimane
    • Beverley Balkau
    • Sabita S. Soedamah-Muthu

    Article Open access 12 April 2022 Pages: 1169 - 1178

    

11. Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes

    • Rebecca C. Wyatt
    • William A. Hagopian
    • Matthew B. Johnson

    Short Communication Open access 30 April 2022 Pages: 1179 - 1184

    

12. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade

    • Emi Kawada-Horitani
    • Shunbun Kita
    • Iichiro Shimomura

    Article Open access 05 May 2022 Pages: 1185 - 1197

    

13. The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis

    • Mouna El Mehdi
    • Saloua Takhlidjt
    • Marie Picot

    Article 27 April 2022 Pages: 1198 - 1211

    

14. Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia

    • Svenja Meyhöfer
    • Katharina Dembinski
    • Sebastian M. Meyhöfer

    Article Open access 21 April 2022 Pages: 1212 - 1221

    

15. Paternal eNOS deficiency in mice affects glucose homeostasis and liver glycogen in male offspring without inheritance of eNOS deficiency itself

    • Berthold Hocher
    • Yong-Ping Lu
    • Ahmed A. Hasan

    Article Open access 30 April 2022 Pages: 1222 - 1236

    

16. Correction to: Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function

    • Moneeza K. Siddiqui
    • Ranjit Mohan Anjana
    • Viswanathan Mohan

    Correction Open access 26 April 2022 Pages: 1237 - 1237